CDKN2A and cancer: That our own analyses of associations between clinico-pathological parameters of cancer aggressiveness and p16 expression mostly revealed only weak or even no associations seems to suggest, that p16 overexpression is not a feature that is dramatically linked to lethal cancer cell properties.